WHO and other public health agencies are not considering this fact in their risk-benefit analysis, especially for repurposed drugs with well-known side-effect profiles: the risk is small but the benefits are profoundly important and could be confirmed within just days. That’s too long during a pandemic undergoing exponential growth. This shows why the single-minded focus of relying on RCT’s is severely misguided in the midst of a pandemic. It’s extent could have been radically cut within just days. We would not have had to suffer through the pandemic for 18 months. or other countries we would have known within days that they had indeed been successful. To me that is a stunning fact, if any of these proposed medications really is effective for EARLY treatment, then if they had been used wide-spread for EARLY treatment in the U.S. Then IF a proposed medication really is successful for EARLY treatment of COVID-19, we will have evidence of that within days, indicated by the reduction of hospitalizations. Here’s a stunning fact when you think about it:įor COVID, IF your case is going to require hospitalization it will happen on average within 7 days of symptoms appearing. Then for a global epidemic it makes no logical sense to not allow its use under a doctors care, at least under an emergency use authorization. So WHO acknowledges IVM’s safety for wide spread use. However, I used the search function on the WHO site and that page no longer turns up. If you go to that link now though you’ll get an error message that WHO has been revamping its site since 2020 and some pages have been moved. Note the link I gave above is the one from the site, a site that archives previous web pages. However, when I went to the link on the WHO site recently, that page is no longer there. Mass treatment with ivermectin: an underutilized public health strategy
It was discussed on some online forums that WHO on it’s web site lauded ivermectin for its safety and effectiveness for treating parasitic disease:
Did WHO wipe from its web site a positive ivermectin report for safety?
0 kommentar(er)
